To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Relay Therapeutics goes public
Relay Therapeutics, a precision medicine company, has raised $400 million for its IPO after pricing its 20 million shares at $20 per share.
